LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (NASDAQ: CBRX) today reported financial results for the three- and six-month periods ended June 30, 2007. Highlights for and subsequent to the quarter include: * Net revenues of $7.3 million, a 32% increase from $5.5 million in the second quarter of 2006. * Operating expenses of $6.3 million, a 23% increase from $5.1 million in the second quarter of 2006. The 2007 quarter included a $1.3 million non-cash quarterly amortization charge for the December 2006 acquisition of U.S. marketing rights for CRINONE® (progesterone gel); there was no comparable charge in the 2006 quarter.
